中環新能源(01735.HK)與廣州融捷訂立戰略合作框架協議
格隆匯5月7日丨中環新能源(01735.HK)發佈公吿,2025年5月7日,廣州融捷能源科技有限公司(“廣州融捷”)與公司間接全資附屬公司中環低碳新能源(安徽)集團有限公司(“中環低碳”)訂立戰略合作框架協議,據此,該協議訂約方擬推進碳峯值行動及促進資源高效利用及綠色低碳發展、發揮各自優勢及需求,按照中國“碳達峯”及“碳中和”的重要戰略方針,本着優勢互補、互惠互利、共同發展的原則,共同發展新能源及綠色能源產業。
根據披露,廣州融捷主要從事(其中包括)新能源、顯示技術、教育科技、生物醫藥資源開發及加工、技術創新及金融投資行業。其中,廣州融捷專門研究及生產“低温長壽”鋰電池。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.